share_log

康希諾生物：董事會會議通知

CANSINOBIO: NOTICE OF BOARD MEETING

香港交易所 ·  Mar 15 04:50
Summary by Moomoo AI
康希諾生物股份公司（「本公司」）將於2024年3月27日（星期三）召開董事會會議，屆時將考慮及批准公司及其附屬公司截至2023年12月31日止年度的全年業績及其發佈。會議同時將討論建議派發年度股息的事宜（如有）。本次會議由董事長Xuefeng YU領導，並於2024年3月15日通過公告形式告知。董事會成員包括執行董事Xuefeng YU博士、Shou Bai CHAO博士及王靖女士；非執行董事梁頴宇女士，以及獨立非執行董事桂水發先生、劉建忠先生及張耀樑先生。
康希諾生物股份公司（「本公司」）將於2024年3月27日（星期三）召開董事會會議，屆時將考慮及批准公司及其附屬公司截至2023年12月31日止年度的全年業績及其發佈。會議同時將討論建議派發年度股息的事宜（如有）。本次會議由董事長Xuefeng YU領導，並於2024年3月15日通過公告形式告知。董事會成員包括執行董事Xuefeng YU博士、Shou Bai CHAO博士及王靖女士；非執行董事梁頴宇女士，以及獨立非執行董事桂水發先生、劉建忠先生及張耀樑先生。
Consino Biological Corporation (the “Company”) will hold a Board meeting on Wednesday, March 27, 2024, at which time the Company and its subsidiaries will consider and approve the annual results and their publication for the year ended 31 December 2023. The meeting will also discuss, if any, the proposed distribution of annual dividends. The meeting was chaired by Chairman Xuefeng YU and announced on March 15, 2024. The members of the Board of Directors include Executive Directors Dr. Xuefeng YU, Dr. Shou Bai CHAO and Ms. Wang Jing; Ms. Leung Wing Yu, Non-Executive Director, and Mr. Kwai Shuifa, Mr. Liu Jianzhong and Mr. Zhang Yiu Leung.
Consino Biological Corporation (the “Company”) will hold a Board meeting on Wednesday, March 27, 2024, at which time the Company and its subsidiaries will consider and approve the annual results and their publication for the year ended 31 December 2023. The meeting will also discuss, if any, the proposed distribution of annual dividends. The meeting was chaired by Chairman Xuefeng YU and announced on March 15, 2024. The members of the Board of Directors include Executive Directors Dr. Xuefeng YU, Dr. Shou Bai CHAO and Ms. Wang Jing; Ms. Leung Wing Yu, Non-Executive Director, and Mr. Kwai Shuifa, Mr. Liu Jianzhong and Mr. Zhang Yiu Leung.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more